Atopic dermatitis (eczema) trials in France

In France 20 Also abroad 251

20 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 10 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema
Where
Lille, Paris, Rouen Cedex, Toulouse
Age
18 years to 64 years
People
165 worldwide
Run by
Pfizer
See details and how to joinNCT07216027 · EU 2025-522965-31-00
No phaseTaking people
Observational Analytical Validation Study of the Replior ScratchSense
Where
Grenoble
Age
18 years to 65 years
People
35
Run by
Replior AB
See details and how to joinNCT07909967
Phase 2Taking people
A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
Where
Martigues
Age
18 years and over
People
350 worldwide
Run by
Apogee Therapeutics, Inc.
See details and how to joinNCT07003425
No phaseTaking people
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
Where
Besançon, Chalon-sur-Saône, Le Mans, Mulhouse, Romans-sur-Isère, Saint-Pierre, Valence
Age
12 years and over
People
1,000 worldwide
Run by
Sanofi
See details and how to joinNCT07290803
Phase 3Enrolling by invitation
A Study to Assess the Long-Term Safety and Efficacy of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis
Where
Nantes, Romans-Sur-Isere, Toulouse Cedex 9
Age
6 months to 18 years
People
338 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT05735483 · EU 2022-501478-21-00
Phase 3Not yet taking people in France
A Study of Lebrikizumab in Adults and Adolescents With Face and Neck Atopic Dermatitis
Where
Bordeaux, Clermont-Ferrand, Dijon, Grenoble Cedex 9, Le Mans Cedex 9, Lille Cedex, Nantes, Niort, Paris, Paris Cedex 18, Pierre-Bénite, Poitiers, Rennes, Rouen Cedex, Saint-Priest-en-Jarez, Toulon Cedex 9
Age
12 years and over
People
230 worldwide
Run by
Almirall, S.A.
See details and how to joinNCT07873801 · EU 2025-525133-31-00
Phase 2Taking people
Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
Where
Brest, Lille, Lorient, Nantes, Nice, Paris, Pierre-Bénite, Reims, Rouen Cedex
Age
18 years to 100 years
People
224 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT06947993 · EU 2024-519081-49-00
No phaseTaking people
Double-blind, Randomized, Non-inferiority Trial in Atopic Dermatitis: Comparison of Lipikar Balm and Relipid+ Balm in the Treatment of Mild to Moderate Atopic Dermatitis in Children and Adults
Where
Caen
People
86
Run by
University Hospital, Caen
See details and how to joinNCT07358000
Phase 1Taking people
A Phase 1 first-in-human study to evaluate SAR447754 in healthy adult participants and in adult participants with moderate-to-severe atopic dermatitis.
Where
Marseille
Age
18 years to 64 years
People
291 worldwide
Run by
Sanofi-Aventis Recherche & Developpement
See details and how to join2025-523826-41-00 · EU 2025-523826-41-00
Phase 2Taking people
A Study to Evaluate the Long-term Safety and Effectiveness of APG777 in Subjects with Atopic Dermatitis
Where
Martigues
Age
18 years and over
People
175 worldwide
Run by
Apogee Therapeutics Inc.
See details and how to join2024-519795-11-00 · EU 2024-519795-11-00
No phaseTaking people
Effect of Partially Hydrolyzed Formula With Synbiotics on Skin Barrier Function
Where
Amiens, Caen, Grenoble, Lyon, Rouen, Tours
Age
1 day to 14 days
People
400 worldwide
Run by
Société des Produits Nestlé (SPN)
See details and how to joinNCT06943469
No phaseTaking people
Reflectance Confocal Microscopy Evaluation of Skin Structure of Patients With Atopic Dermatitis Under Nemolizumab
Where
Romans-Sur-Isere
Age
18 years and over
People
15
Run by
Hôpitaux Drôme Nord
See details and how to joinNCT07730788
No phaseTaking people
A Study to Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic Dermatitis.
Where
Amiens, Besançon, Bezannes, Bordeaux, Brest, Caen, Calais, Chalon-sur-Saône, Clermont-Ferrand, Créteil, Dijon, Levallois-Perret, Lille, Martigues, Montpellier, Mulhouse, Nantes, Paris, Pierre-Bénite, Rennes, Romans-sur-Isère, Rouen, Saint-Germain-en-Laye, Saint-Mandé, Toulouse, Valenciennes, Vandœuvre-lès-Nancy
Age
18 years and over
People
183
Run by
Pfizer
See details and how to joinNCT05689151
No phaseEnrolling by invitation
Analysis of Inflammation in the Vitiligo and Other Inflammatory Skin Diseases: Psoriasis, Atopic Dermatitis and Alopecia Areata
Where
Bordeaux
Age
18 years to 75 years
People
450
Run by
University Hospital, Bordeaux
See details and how to joinNCT03976622
No phaseTaking people
Identification of Cutaneous and Blood Biomarkers Predictive of Response to Systemic Treatments During Chronic Inflammatory Skin Diseases
Where
Paris
Age
18 years and over
People
830
Run by
Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT06599411
No phaseTaking people
Study of Alloknesia in Atopic Dermatitis
Where
Angers, Brest, La Roche-sur-Yon, Lorient, Nantes, Rennes, Tours, Vannes
Age
18 years and over
People
160
Run by
University Hospital, Brest
See details and how to joinNCT06923202
No phaseTaking people
Deployment o the Multidisciplinary Prospective Cohort Imminent
Where
Lille
Age
18 years and over
People
2,200
Run by
University Hospital, Lille
See details and how to joinNCT04334031
No phaseTaking people
Clinico-biological Collection of Autoimmune, Dysimmune or Auto-inflammatory Dermatological Diseases
Where
Toulouse
Age
6 years to 99 years
People
800
Run by
University Hospital, Toulouse
See details and how to joinNCT06387654
No phaseTaking people
Frequency of Palpebral Involvement in Adult With Atopic Dermatitis
Where
Lille, Rouen
Age
18 years and over
People
550
Run by
University Hospital, Lille
See details and how to joinNCT04826744
Phase 3Taking people
Efficacy and Safety of Methotrexate Versus Placebo in Adults With Atopic Dermatitis.
Where
Bordeaux, Pierre-Bénite
Age
18 years and over
People
277 worldwide
Run by
medac GmbH
See details and how to joinNCT06239311 · EU 2023-504443-13-00